Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	View
JXSL2101118	OAV101注射液	onasemnogene abeparvovec	Injection	Biological Products(2.1)	Import Drug Application	2021-10-21	China Novartis Institutes For Biomedical Research Co Ltd;Novartis Pharma Schweiz AG	view
JTS2500039	OAV101 注射液			Biological Products	Disposable Import Drug Application	2025-06-06	Beijing Novartis Pharma Co Ltd;Novartis Pharma Schweiz AG;Novartis Gene Therapies Inc	view
JTS2500038	OAV101			Biological Products	Disposable Import Drug Application	2025-06-06	Beijing Novartis Pharma Co Ltd;Novartis Pharma Schweiz AG;Novartis Gene Therapies Inc	view
JXSB2300032	OAV101注射液	onasemnogene abeparvovec	Injection	Biological Products	Supplementary Application	2023-03-24	Novartis Pharma Schweiz AG;Novartis Gene Therapies Inc	view
JXSB2200138	OAV101注射液	onasemnogene abeparvovec	Injection	Biological Products	Supplementary Application	2022-10-27	Novartis Pharma Schweiz AG;Novartis Gene Therapies Inc	view